| Full course regimen | Sub-therapeutic regimen |  | ||
---|---|---|---|---|---|
Year | N | F | N | F | Â |
1983 (n = 56) | 53 | 95% | 3 | 5.4% | Pre-resistance phase |
1985 (n53) | 50 | 94.3% | 3 | 5.7% | Â |
1987 (n = 52) | 52 | 100% | 0 | 0 | Phase of emerging resistance |
1989 (n = 46) | 46 | 100% | 0 | 0 | Â |
1992 (n = 49) | 47 | 95.9% | 2 | 4.1% | Â |
1995 (n = 39) | 36 | 92.3% | 3 | 7.7% | Phase of resistance dissemination |
1997 (n = 47) | 47 | 100% | 0 | 0 | Â |